Face­book bil­lion­aires Pe­ter Thiel and Sean Park­er back­ing a stealth im­munother­a­py biotech — re­port

See­ing any bil­lion­aire back a biotech start­up is al­ways in­trigu­ing. But when you pair Pe­ter Thiel and Sean Park­er as the deep pock­ets be­hind a new T cell com­pa­ny, tongues will wag.

CN­BC’s Christi­na Farr has start­ed the buzz, say­ing the fab­u­lous­ly wealthy Face­book ami­gos have chipped in to a $12 mil­lion seed round for one 3T Bio­sciences. Quot­ing sources, Farr says 3T is work­ing with sci­en­tists at the lab of Stan­ford’s Christo­pher Gar­cia. And they are work­ing on can­cer im­munother­a­pies, the hottest field in the R&D are­na these days.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER